ICAM1 antibody drug conjugates exert potent antitumor activity in papillary and anaplastic thyroid carcinoma

Treatment options for anaplastic thyroid cancer (ATC) and refractory papillary thyroid carcinoma (PTC) are limited and outcomes remain poor. In this study, we determined via bioinformatic expression analyses and immunohistochemistry staining that intercellular adhesion molecule-1(ICAM1) is an attrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Peng, Tao, Changjuan, Shimura, Takaya, Huang, Andrew C., Kong, Nana, Dai, Yujie, Yao, Shili, Xi, Yun, Wang, Xing, Fang, Jianmin, Moses, Marsha A., Guo, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371847/
https://www.ncbi.nlm.nih.gov/pubmed/37520726
http://dx.doi.org/10.1016/j.isci.2023.107272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371847/
https://www.ncbi.nlm.nih.gov/pubmed/37520726
http://dx.doi.org/10.1016/j.isci.2023.107272

Ejemplares similares